poisar

Stock

Glaukos Corporation GKOS

$243.24-0.64%

Overview

GKOS market data

Business OverviewA provider-written description of this company or fund, with its source and observation date.

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Official website

Source
massive
Observed
Cadence
Reference data reviewed periodically
Status
fresh

Price HistoryDaily closing prices from recorded market data. The latest point represents the most recent completed daily period; prices can move before the next point appears.

GKOS price chart · 1M
O
245.71
H
246.56
L
239.96
C
243.24
Vol
55,726.00

Daily history from Jan 4, 2016

Source
US equities market feed
Observed
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & PerformanceOpen, range, return and notional-volume facts calculated from daily market bars.

Open
$245.71
Previous Close
$244.81
Day High
$246.56
Day Low
$239.96
52 Week High
$254.89
52 Week Low
$87.72
7 Day Return
+2.94%
30 Day Return
+45.69%
90 Day Return
+28.32%
1 Year Return
+175.25%
Daily Notional Volume
$13.6M
Latest daily bar volume multiplied by its closing price.

Valuation & ProfitabilityProvider-backed valuation, profitability, and range metrics for the selected company. Display-only; never feeds scores or decisions.

Provider-backed
P/E (TTM)
—
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
—
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$3.28
Diluted earnings per share over the trailing twelve months.
Beta
0.67
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
—
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-24.6%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$87.32 – $255.19
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
—
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $14.5B · P/B 9.88 · P/S 21.03.

Company NewsRecent source-attributed headlines linked to this symbol. Repeated headlines and low-signal items are filtered. Open a headline for its source and context.

10 captured

Decision & ScoreThis analysis is included with a paid membership. Public prices, charts and source-attributed news remain available without a subscription. Membership does not guarantee an investment outcome.

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern EvidenceThis analysis is included with a paid membership. Public prices, charts and source-attributed news remain available without a subscription. Membership does not guarantee an investment outcome.

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer RankingThis analysis is included with a paid membership. Public prices, charts and source-attributed news remain available without a subscription. Membership does not guarantee an investment outcome.

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock